SAN FRANCISCO—Tardive dyskinesia (TD) is strongly linked with older age, medical comorbidity, and hospitalizations, according to a study of US veterans with serious mental illness presented during a poster session at the American Psychiatric Association’s annual meeting.

SAN FRANCISCO—A once-daily asenapine patch is effective for the treatment of schizophrenia in adults, researchers reported during a poster session at the American Psychiatric Association’s annual meeting.

SAN FRANCISCO—Cognitive behavioral therapy (CBT), commonly recommended as part of a treatment plan for mood disorders, can also be an effective intervention for psychotic disorders, a presenter at the American Psychiatric Association’s annual meeting argued.

SAN FRANCISCO—Adding samidorphan to olanzapine did not diminish the antipsychotic efficacy of olanzapine alone in adults with schizophrenia, according to data presented during a poster session at the American Psychiatric Association’s annual meeting.

SAN FRANCISCO—A sample of hospital inpatients with schizophrenia spectrum disorders was prescribed a long-acting injectable (LAI) at a markedly higher rate than the national average, researchers reported at the American Psychiatric Association’s annual meeting.

SAN FRANCISCO—Patient age is significantly associated with the type of extrapyramidal symptoms that stem from antipsychotic use, according to a study presented during a poster session at the American Psychiatric Association’s annual meeting.